UROKINASE
- Cadila stock touches 52 week high after gettting USFDA approval for two generic drugsAccording to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...
- Zydus Cadila concludes deal to re-launch Urokinase drugZydus Cadila concludes agreement with Canadian biotech company Microbix Biosystems to re-launch KINLYTIC, a life saving drug in North Ameri...
- Cadila Q4 net dips 4.52% to Rs 171 croreThe company had posted a net profit of Rs 178.97 crore for in the same quarter last fiscal, Cadila Healthcare said in a filing to BSE.
- Hits and Misses: Everonn Education, Heidelberg Cement, HDIL & Cadila HealthcareShares of Everonn Education, India's largest technology-enabled education firm, were locked at the 20% upper circuit of 395.85 on Monday.
Cashless mediclaim: Insurers to buy equipment, drugs directlyPublic sector health insurance companies are proposing to order and pay for medicines and medical equipment themselves.
Load More- Hits and Misses: Everonn Education, Heidelberg Cement, HDIL & Cadila Healthcare